The global menopause Market is anticipated to grow at a CAGR of 5.37 % during the forecast period (2023-2030). Menopause is associated with a range of physical and mental symptoms. Hormone Replacement Therapy (HRT) aims to alleviate these symptoms, while other treatments focus on managing them, maintaining bone and heart health, improving vaginal health, and addressing mental health and cognitive function. Furthermore, the market’s growth is attributed to increasing education and awareness. Menopause and its effects on women's health have grown more widely recognized. The data gathering and insights provided by the application contribute to educating women about their symptoms and relevant management solutions. For instance, in February 2023, Morrama launched the development of an AI-powered management app to support women going through the menopause. The software collects data on body temperature, energy levels, stress, and sleep using machine learning.
Browse the full report description of “Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/menopause-market
Furthermore, consumer Education and Awareness have increased around the issues related to menopause and the available treatments. Participating in an event such as CPHI Barcelona provides an opportunity to inform consumers and industry professionals about the softgel products., in August 2023, Sirio launched new softgels targeted at customers that seek to innovate in the consumer health space at CPHI Barcelona at CPHI Barcelona. The new formulations are intended to fulfill the growing consumer demand for products with more natural active ingredients for both menopause and enhanced eye health.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Treatment
o By Route of Administration
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Bayer AG, Dr.Reddy’s Laboratories Ltd, Merck & Co., Inc.,
Novo Nordisk A/S, Procter & Gambleand others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Menopause Market Report Segment
By Treatment
o Hormonal
o Non-hormonal
By Route of Administration
By Distribution Channel
Global Menopause Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/menopause-market